PHF8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.03460018330281E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.56869994771824E-09 |
Normal-vs-Stage2 |
4.586700019793E-09 |
Normal-vs-Stage3 |
2.85150014711633E-10 |
Normal-vs-Stage4 |
1.90270021960259E-11 |
Stage1-vs-Stage2 |
2.648600E-01 |
Stage1-vs-Stage3 |
2.342000E-01 |
Stage1-vs-Stage4 |
3.143900E-02 |
Stage2-vs-Stage3 |
9.884400E-01 |
Stage2-vs-Stage4 |
5.531000E-01 |
Stage3-vs-Stage4 |
5.435400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.31070043707382E-10 |
Normal-vs-AfricanAmerican |
2.75830025486812E-10 |
Normal-vs-Asian |
3.698800E-01 |
Caucasian-vs-AfricanAmerican |
2.357400E-01 |
Caucasian-vs-Asian |
3.910300E-02 |
AfricanAmerican-vs-Asian |
1.460210E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
7.23320292550511E-11 |
Normal-vs-Female |
7.73410002707919E-10 |
Male-vs-Female |
3.290400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.27390000162586E-08 |
Normal-vs-Age(41-60Yrs) |
1.41370004591579E-09 |
Normal-vs-Age(61-80Yrs) |
9.31069665810469E-11 |
Normal-vs-Age(81-100Yrs) |
9.06599999517255E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.101400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.213000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.029200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.298200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.766230E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.016400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.384000E-03 |
Normal-vs-Grade 2 |
1.84000004121998E-09 |
Normal-vs-Grade 3 |
1.88304927206673E-12 |
Normal-vs-Grade 4 |
3.10473868836425E-12 |
Grade 1-vs-Grade 2 |
1.057820E-01 |
Grade 1-vs-Grade 3 |
1.072430E-02 |
Grade 1-vs-Grade 4 |
2.243200E-03 |
Grade 2-vs-Grade 3 |
1.759610E-01 |
Grade 2-vs-Grade 4 |
4.797900E-03 |
Grade 3-vs-Grade 4 |
1.078970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.46680003885325E-09 |
Normal-vs-ccB subtype |
5.59999824290003E-11 |
ccA subtype-vs-ccB subtype |
1.609610E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.07060044058005E-10 |
Normal-vs-N1 |
2.19830000003363E-06 |
N0-vs-N1 |
4.487400E-01 |
|
|